Publication | Closed Access

Compound 511 ameliorates MRSA-induced lung injury by attenuating morphine-induced immunosuppression in mice via PI3K/AKT/mTOR pathway

Acute Lung InjuryInflammationAnti-inflammatoryInflammatory Lung DiseaseLung InflammationMedicineImmunologyMechanism Of ActionPulmonary PharmacologyMorphine-induced ImmunosuppressionMrsa-induced Lung InjuryPharmacotherapyExperimental PharmacologyPi3k/akt/mtor PathwayPharmacologyLung Cancer